Cargando…
Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective Promoter
SIMPLE SUMMARY: The rat progression elevated gene-3 (PEG-3) promoter displays cancer-selective expression, whereas the rat growth arrest and DNA damage inducible gene-34 (GADD34) promoter lacks cancer specificity. PEG-3 and GADD34 minimal promoters display strong sequence homology except for two sin...
Autores principales: | Bhoopathi, Praveen, Pradhan, Anjan K., Kumar, Amit, Maji, Santanu, Mannangatti, Padmanabhan, Deng, Xiaoyan, Bandyopadhyay, Dipankar, Sarkar, Devanand, Wang, Xiang-Yang, Landry, Joseph W., Das, Swadesh K., Emdad, Luni, Fisher, Paul B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946048/ https://www.ncbi.nlm.nih.gov/pubmed/35326649 http://dx.doi.org/10.3390/cancers14061497 |
Ejemplares similares
-
Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor
por: Pradhan, Anjan K., et al.
Publicado: (2022) -
Theranostic Tripartite Cancer Terminator Virus for Cancer Therapy and Imaging
por: Bhoopathi, Praveen, et al.
Publicado: (2021) -
Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity
por: Bhoopathi, Praveen, et al.
Publicado: (2023) -
Regulation of neuroblastoma migration, invasion and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin
por: Bhoopathi, Praveen, et al.
Publicado: (2019) -
Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking
por: Pradhan, Anjan K., et al.
Publicado: (2019)